DALLAS & ORLANDO, Fla.--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present its EVA pharmaceutical material solutions at the 2015 AAPS Annual Meeting and Exposition in Orlando, Fla. Celanese will exhibit its pharmaceutical controlled release copolymer, VitalDose® EVA, October 25-29, 2015 at booth 316.
Celanese material experts will discuss the latest developments in pharmaceutical material science and how ethylene vinyl acetate (EVA) is being used in new drug delivery innovations. VitalDose® EVA controlled release excipients deliver reliable performance with customizable release properties that are compatible with many active pharmaceutical ingredients.
“The unique properties of EVA controlled release excipients allow for customizable delivery rates that are expanding pharmaceutical possibilities,” said Kelsey Achenbach, Celanese strategic marketing manager. “VitalDose EVA offers flexible delivery systems and process versatility backed by high-touch technical expertise to assist from project conception through design and regulatory approval.”
Celanese Presentation Sessions:
- Kelsey Achenbach, strategic marketing manager, will present “Driving Pharmaceutical Innovation with EVA” on Monday, October 26, 2015 at 2:05 p.m.
- Jose Reyes, strategic marketing manager, will present “EVA Foamed Excipient: Novel Way to Deliver Stem Cells, Growth Factors, and Biologics for Controlled Release Applications” in a poster presentation on Tuesday, October 27, 2015 at 8:30 a.m.
For more information about Celanese’s controlled release pharmaceutical EVA polymer, VitalDose® EVA, please visit www.vitaldose.com.
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,500 employees worldwide and had 2014 net sales of $6.8 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
All registered trademarks are owned by Celanese International Corporation or its affiliates.
This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or any of its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.